Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Evaluating Sepsis Patient's Disease Severity and Prognosis

NCT03340649 is registered in ClinicalTrials.gov with Jingyuan,Xu as lead sponsor.

NCT NCT03340649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03340649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Evaluating Sepsis Patient's Disease Severity and Prognosis
Lead sponsor
Jingyuan,Xu
Phase
Observational
Overall status
Unknown status
Start date
November 9, 2017
Completion date
March 1, 2018
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis